Skip to content
Aminoscope
Pillar

GLP-1 medications, read straight from the trials.

Semaglutide, tirzepatide, and the incretin pipeline. Efficacy magnitudes, cardiovascular outcomes, side-effect timelines, access, and cost — every figure tied to its source trial or FDA label.

placebo −2.4%−14.9%MEAN BODY-WEIGHT CHANGE · 68 WEEKS

What the semaglutide weight-loss trials actually showed

STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.